Status:
UNKNOWN
Home Monitoring in the Management of Hypertension and Diabetes Mellitus
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Conditions:
Hypertension
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The home monitoring of automated measuring devices may improve the management of the chronic diseases, and may decrease the incidence of fatal disease. The investigators conducted a small sample and s...
Detailed Description
Background: Approximately 40% of type 2 diabetes patients are also with hypertension. There are many risk factors in these patients, and so it's difficult to manage these patients. With the improveme...
Eligibility Criteria
Inclusion
- Regardless of whether they are currently receiving antihypertensive therapy, systolic blood pressure higher than 140 mmHg or diastolic blood pressure higher than 90 mmHg.
- Whether or not use oral hypoglycemic agents or insulin injections, the fasting plasma is higher than 7.0 mmol/L, or postprandial blood glucose higher than 11.1 mmol/L.
Exclusion
- With life-threatening disease.
- With the various effects of metabolic diseases such as hyperthyroidism, hypothyroidism, etc.
- Stroke, myocardial infarction and other serious cardiovascular and cerebrovascular diseases occurred within 3 months.
- Serum creatinine level higher than 176.8 mmol/L
- Dementia or severe cognitive decline
- Unable to do a long-term follow-up or do not agree to participate in this trial.
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2009
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00968786
Start Date
August 1 2008
End Date
September 1 2009
Last Update
August 31 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.